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Extratumoral Vascular Invasion Is a Significant Prognostic
Indicator and a Predicting Factor of Distant Metastasis in
Non-small Cell Lung Cancer
Yoshihisa Shimada, MD,* Genichiro Ishii, MD,† Tomoyuki Hishida, MD,* Junji Yoshida, MD,*
Mitsuyo Nishimura, MD,* and Kanji Nagai, MD*
Introduction: Vascular invasion is thought to be a fundamental step
in hematogenous metastasis. The aim of this study was to assess
whether the qualitative evaluation of vascular invasion according to
its location (intratumoral or extratumoral) could provide an appro-
priate means of predicting the prognostic outcome and potential
patterns of recurrence in non-small cell lung cancer.
Methods: We reviewed the cases of 1000 consecutive patients in
whom complete resection of non-small cell lung cancer had been
performed. Sections stained by the Victoria blue van Gieson method
were examined for the presence of vascular invasion and the eval-
uation of its location (v0: absence, n  540; v1: intratumoral, n 
428; v2: extratumoral, n  32). Survival was estimated using the
Kaplan-Meier method. To determine independent prognostic fac-
tors, univariate and multivariate analyses were conducted.
Results: The study cohort included 605 men and 395 women, with
a mean age of 66 years (range, 20–90 years). The 5-year overall
survival rate of the vascular invasion-negative group and the vas-
cular invasion-positive group was 82.5% and 55.1%, respectively
(p 0.001), and the 5-year overall survival rates of the v1 group and
v2 groups were 55.9% and 44.0%, respectively (p  0.010). Mul-
tivariate analysis showed that location of the vascular invasion
(v0–1 versus v2) (p  0.049), age (p  0.030), tumor size (p 
0.004), lymph node metastasis (p  0.001), and pleural invasion
(p  0.001) were significant prognostic factors. The proportion of
patients who developed distant metastasis was significantly higher in
the v2 group than in the v1 group (p  0.026).
Conclusion: Evaluation of vascular invasion location was a statis-
tically significant predictor of prognosis and potential recurrence
patterns.
Key Words: Vascular invasion, Extratumoral, Intratumoral, Prog-
nostic factor, NSCLC.
(J Thorac Oncol. 2010;5: 970–975)
Metastasis is a complex, multistep process that ultimatelyresults in the formation of a mature tumor, which leads
to the death of almost all cancer patients. Many investigators
have elucidated the mechanisms of how tumor cells invade
into intratumoral blood vessels within primary cancers and
emphasized the biologic importance of this process for tumor
metastasis.1 Vascular invasion (blood vessel invasion) is now
considered to be a fundamental step in hematogenous metas-
tasis,1 and the presence of vascular invasion by cancer cells is
one of the most important prognostic factors in many types of
cancer including non-small cell lung cancer (NSCLC), and it
is also thought to directly represent the metastatic process.2,3
On routine histologic examination, vascular invasion
was defined as definite tumor cell embolization in the vascu-
lar lumen on hematoxylin and eosin and elastic lamina
staining. Previous reports have indicated that the existence of
intratumoral vascular invasion was associated with unfavor-
able prognosis in NSCLC1–16; however, almost all intratu-
moral blood vessels are occluded by surrounding tumor cells
and stromal cells. This may mean that the intratumoral blood
vessels are not functional. Therefore, it is unknown whether
tumor cell embolization in intratumoral blood vessels could
clearly represent one step of the metastatic process with
respect to hematogenous metastasis. However, because ex-
tratumoral blood vessels are thought to be functional blood
vessels, the existence of extratumoral vascular invasion may
be a potential factor of distant metastasis.
Previously, we investigated whether the qualitative
evaluation of lymphatic permeation according to its location
provides appropriate means of predicting outcomes in con-
secutive patients with surgically treated NSCLC and found
that extratumoral lymphatic permeation showed a signifi-
cantly shorter recurrence-free survival (RFS) time compared
with intratumoral lymphatic permeation.17 We concluded that
extratumoral lymphatic permeation might be an early phase
of carcinomatous lymphangiosis.
The objective of this study was to assess whether the
qualitative evaluation of vascular invasion according to its
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location (intratumoral or extratumoral) could provide an ap-
propriate means of predicting the outcome and potential
patterns of cancer recurrence in NSCLC.
PATIENTS AND METHODS
Patients
During the period from August 2001 to October 2005,
a total of 1043 patients underwent surgical resection for
primary lung cancer at our hospital, and we reviewed the
cases of the 1000 consecutive patients in whom complete
resection of NSCLC had been possible. Their median fol-
low-up period was 4.1 years. All patients signed the Institu-
tional Review Board-approved informed consent form. Pa-
tients who had received preoperative chemotherapy or
preoperative thoracic radiation were excluded. The preoper-
ative evaluation included a physical examination, bronchofi-
berscopy, chest radiography, computed tomography of the
chest and abdomen, magnetic resonance imaging of the brain,
and an isotopic bone scan. The majority of patients under-
went lobectomy or pneumonectomy for resection of the
primary lesion. In cases of wedge resection or segmentecto-
mies, lavage cytology at the surgical margin was evaluated by
intraoperative rapid cytologic diagnosis and confirmed as
negative. Staging was performed according to the tumor node
metastasis classification of the International Union Against
Cancer. The tumors were histologically classified and graded
according to the World Health Organization guidelines, third
edition.
Histopathology
The available pathology slides from all 1000 surgical
specimens were reviewed in this study. After fixing the
specimens with either 10% formalin or cold methanol and
embedding them in paraffin, serial 4-m sections were
stained with hematoxylin and eosin and by the Victoria blue
van Gieson to visualize elastic fibers. Sections stained by
Victoria blue van Gieson were examined for the presence of
vascular invasion and pleural invasion. The presence of
vascular invasion was determined by identifying conspicuous
clusters of intravascular cancer surrounded by an elastic
layer. Since August 2001, we have been recording the loca-
tion of vascular invasion according to our histologic criteria.
The presence or absence of vascular invasion and its recorded
location are shown in Table 1: v0, absence of vascular
invasion; v1, presence of intratumoral vascular invasion (Fig-
ures 1A, B), and v2, presence of extratumoral vascular inva-
FIGURE 1. Vascular invasion in a Victo-
ria blue van Gieson (VvG)-stained section
of non-small cell lung cancer. These fig-
ures show intratumoral vascular invasion
(v1) within a tumor nest in hematoxylin
and eosin (HE) staining (A; arrow) and
VvG staining (B). Findings of extratu-
moral vascular invasion (v2) in HE stain-
ing (C; arrow head) and VvG staining (D)
are shown.
TABLE 1. Definition of Vascular Invasion According to
Location
Grade Definition n (%)
v0 Absence of vascular invasion 540 (54.0)
v1 Presence of intratumoral vascular invasion 428 (42.8)
v2 Presence of extratumoral vascular invasion 32 (3.2)
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sion (Figures 1C, D). If the location of vascular invasion foci
in serial section was clearly out of the primary tumor and not
surrounded by tumor cells at all, we diagnosed it as presence
of extratumoral vascular invasion.
Variables for Prognostic Analysis
Clinical characteristics were retrieved from available
clinical records. The following clinicopathologic factors were
assessed in the retrospective prognostic analysis: age (70
years versus 70 years), gender, pathologic staging, tumor
diameter (3 cm versus 3 cm), pathologic nodal involve-
ment (absence versus presence), vascular invasion (absence
versus presence), extratumoral vascular invasion (absence
[v0–1] versus presence [v2]), pleural invasion (absence ver-
sus presence), lymphatic permeation (absence versus pres-
ence), histology (adenocarcinoma versus other), tumor dif-
ferentiation (well or moderate versus poor), and extent of
resection (pneumonectomy or lobectomy versus segmentec-
tomy or wedge resection).
Statistical Analysis
RFS time was measured as the interval between the
date of surgery and the date of recurrence, the date of death
from any cause, or the most recent date on which the patient
was last known to be alive. Overall survival (OS) was
measured from the date of surgery to the date of death from
any cause or the date on which the patient was last known to
be alive. Survival curves were plotted according to the
Kaplan-Meier method and compared using the log-rank test
in univariate analysis. To determine independent prognostic
factors, multivariate analysis was conducted using the Cox
proportional hazard model. Two-category comparison was
performed by Pearson’s 2 test and Fisher’s exact test for
quantitative data. All tests were two-sided, and p values less
than 0.05 were considered statistically significant. StatView
5.0 software (SAS Institute Inc., Cary, NC) was used to
perform the statistical analysis.
RESULTS
The 5-year OS and RFS rates of all 1000 patients were
69.7% and 59.6%, respectively. Four hundred sixty patients
(46.0%) had tumors with vascular invasion by tumor cells.
Intratumoral vascular invasion (v1) and extratumoral vascular
invasion (v2) were found in 428 and 32 cases, respectively.
All 32 extratumoral vascular invasion cases also had intratu-
moral vascular invasion (data not shown).
Figure 2A shows the RFS curves according to the
results of the examination for vascular invasion (v0 versus v1
versus v2). The 5-year RFS rates of the v0, v1, and v2 groups
were 76.1%, 41.9%, and 21.8%, respectively. The RFS time
of the v2 group was significantly shorter than that of the v1
group (p  0.001), and the difference between the v1 group
and the v0 group (p  0.001) was also significant. Figure 2B
shows the OS curves according to this grouping of vascular
invasion. The 5-year OS rates of the v0, v1, and v2 groups
were 82.5%, 55.9%, and 44.0%, respectively. The OS time of
the v2 group was significantly shorter than that of the v1
group (p  0.010), and the difference between the v1 group
and the v0 group (p 0.001) was also statistically significant.
The study cohort included 605 men and 395 women,
with a mean age of 66 years (range, 20–90 years; SD: 9.9).
The patients’ clinicopathological characteristics and the re-
sults of univariate analysis are shown in Table 2. Clinically
and pathologically significant survival predictors shown by
univariate analysis were age (70 years versus 70 years,
p 0.001), gender (p 0.001), p-staging (p 0.001), tumor
diameter (p  0.001), the presence of lymph node metastasis
(p  0.001), pleural invasion (p  0.001), vascular invasion
(absence [v0] versus presence [v1–2]; p  0.001), extratu-
moral vascular invasion (absence [v0–1] versus presence
[v2]; p  0.001), lymphatic permeation (absence versus
presence; p 0.001), histologic type (adenocarcinoma versus
other; p  0.001), and tumor differentiation (p  0.001).
FIGURE 2. A, Kaplan-Meier recurrence-free survival curve
for patients with non-small cell lung cancer (NSCLC) accord-
ing to a qualitative definition of vascular invasion (v0 versus
v1 versus v2). B, Kaplan-Meier overall survival curve for pa-
tients with NSCLC according to a qualitative definition of
vascular invasion (v0 versus v1 versus v2).
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We tested for a relationship between the presence of
vascular invasion and clinicopathological characteristics and
found a positive correlation with each of the following
clinicopathological factors: age, gender, pathologic stage,
tumor diameter, lymph node metastasis, pleural invasion,
lymphatic permeation, histologic type, tumor differentiation,
and extent of resection (data not shown). A comparison of
clinicopathological factors between the v1 and v2 groups
showed that a statistically significant difference in the v2
vascular invasion positive rate was seen in those at an
advanced pathologic stage, those with lymph node metastasis,
histologic type other than adenocarcinoma, poorly differen-
tiated carcinoma, and the presence of lymphatic permeation
(Table 3).
To determine whether the location of the vascular
invasion was independently significant, multivariate analysis
was performed. The 10 clinicopathological factors that were
assumed to be important survival predictors in the univariate
analysis were included as covariates for the multivariate
analysis. As shown in Table 4, the results show that the
location of the vascular invasion (v0–1 versus v2) was an
independent prognostic factor (p  0.049) but whether there
was vascular invasion presence or absence was not signifi-
cant. In addition, age (p  0.030), tumor size (p  0.004),
lymph node metastasis (p 0.001), and pleural invasion (p
0.001) were also shown to be independent prognostic factors.
To examine whether the location of vascular invasion
could have an impact on cancer recurrence patterns, we also
analyzed the relationship between the location of vascular
invasion (v1 and v2) and the initially observed recurrence
site. (Table 5). One hundred eighty-one patients of the v1
group and 22 patients of the v2 group developed distant
metastases. The 2 test indicated that the proportion of
patients who developed distant metastases was significantly
TABLE 2. Univariate Prognostic Analysis
Factors n (%)
5-yr
OS (%) p
Age (yr)
70 614 (61.4) 73.2
70 386 (38.6) 64.1 0.001
Gender
Male 605 (60.5) 62.5
Female 395 (39.5) 81.2 0.001
p-Stage
I 715 (71.5) 80.5
II 123 (12.3) 50.1
III 157 (15.7) 38.3
IV 5 (0.5) 20.0 0.001
Tumor diameter (mm)
30 590 (59.0) 80.6
30 410 (41.0) 54.4 0.001
Lymph node metastasis
Absence 723 (72.3) 78.9
Presence 252 (25.2) 44.5 0.001
Pleural invasion
Absence 676 (67.6) 81.1
Presence 324 (32.4) 46.2 0.001
Vascular invasion
Absence (v0) 540 (54.0) 82.5
Presence (v1–2) 460 (46.0) 55.1 0.001
Extratumoral vascular invasion
Absence (v0–1) 968 (96.8) 70.6
Presence (v2) 32 (3.2) 44.0 0.001
Lymphatic permeation
Absence 756 (75.6) 75.2
Presence 244 (24.4) 53.6 0.001
Histology
Adenocarcinoma 690 (69.0) 74.3
Other 310 (31.0) 59.7 0.001
Tumor differentiation
Well or moderate 735 (73.5) 74.5
Poor 264 (26.4) 57.0 0.001
Extent of resection
Pneumonectomy or lobectomy 922 (92.2) 69.3
Segmentectomy or wedge 78 (7.8) 75.4 0.231
TABLE 3. Relationship Between Intratumoral
(v1)/Extratumoral (v2) Vascular Invasion and
Clinicopathological Features
Factors
Vascular Invasion
v2-Positive
Rate (%) pv1 v2
Age (yr)
70 237 21 8.1 0.260
70 191 11 5.5
Gender
Male 303 26 7.9 0.206
Female 125 6 4.6
p-Stage
I 234 8 3.3 0.001
II–IV 194 24 11.0
Tumor diameter (mm)
30 169 9 5.1 0.200
30 258 23 8.2
Lymph node metastasis
Absence 240 9 3.6 0.003
Presence 182 22 10.8
Pleural invasion
Absence 200 13 6.1 0.504
Presence 228 19 7.7
Lymphatic permeation
Absence 264 12 4.3 0.007
Presence 164 20 10.9
Histology
Adenocarcinoma 236 10 4.2 0.009
Other 192 22 10.3
Tumor differentiation
Well or moderate 259 11 4.1 0.004
Poor 169 21 11.1
Extent of resection
Pneumonectomy, lobectomy 414 31 7.0 0.964
Segmentectomy, wedge 14 1 7.1
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higher in the v2 group than in the v1 group (p  0.026). The
most common site of distant metastasis in the v1 group was
brain (52 of 113), whereas in the v2 group, it was the
contralateral lung (8 of 19). No differences were noted in
initial progression site.
DISCUSSION
We set out to determine whether qualitative evaluation
of vascular invasion according to location could predict the
outcome and recurrence patterns of NSCLC. In most previous
studies, the presence of vascular invasion was found to be a
significant unfavorable prognostic factor, and vascular inva-
sion should be considered for inclusion in the staging criteria
and indications for adjuvant chemotherapy.7,10,15 In this con-
text, many reports have evaluated vessel invasion (lymphatic
or blood vessel) in terms of the presence of a tumor in the
intratumoral vessel lumen. Miyoshi et al.10 reported that
intratumoral vascular invasion status directly indicates micro-
scopic tumor progression. Macchiarini et al.9 reported that
intratumoral vascular invasion by tumor cells represents one
of the first steps in the metastatic processes of a variety of
neoplasms, including lymph node-negative NSCLC. Fuji-
sawa et al.5 demonstrated that vascular invasion is a very
important prognostic factor in resected NSCLCs with in-
trapulmonary metastasis and might correlate with the ana-
tomic root of pulmonary metastasis. In contrast, other authors
reported no significant correlation between intratumoral vas-
cular invasion and prognosis.18–21 This discrepancy between
the results is considered to have been affected by differences
in histologic type and in the proportion of vascular invasion.
This study showed that both intratumoral and extratu-
moral vascular invasion were the significant prognostic fac-
tors; however, there were significant differences between the
OS and RFS curves of the extratumoral vascular invasion
group and intratumoral vascular invasion group. The pres-
ence or absence of vascular invasion is a significant survival
predictor by univariate analysis but not significant by multi-
variate analysis. Our study indicates that intratumoral vascu-
lar invasion is a significant negative prognostic indicator but
is not so much compared with lymph node metastasis, pleural
invasion, age, or the location of vascular invasion. The
extratumoral vascular invasion group showed significantly
higher incidence of advanced pathologic staging, lymph node
metastasis, lymphatic permeation, and histologic type other
than adenocarcinoma in curatively resected NSCLC. More-
over, the proportion of patients who developed distant me-
tastasis was significantly higher in the extratumoral vascular
invasion group than in the intratumoral vascular invasion
group. It is assumed that extratumoral blood vessels are part
of the pulmonary vascular circuit and functional vasculature,
whereas intratumoral blood vessels might not always be
functional vasculature, because almost all intratumoral blood
vessels are occluded by surrounding tumor cells and stromal
cells. Therefore, extratumoral vascular invasion may more
adequately reflect only a phase of hematogenous metastasis
processes.
We had found that extratumoral lymphatic permeation
showed significantly shorter RFS time compared with intra-
tumoral lymphatic permeation,17 and that the evaluation of
vessel invasion according to its location also had an important
impact on prognostic outcome. In our study cohort, intratu-
moral lymphatic permeation and extratumoral lymphatic per-
meation were found to be 152 and 92 cases, and the 5-year
OS rates were 64.1% and 32.7% (p  0.001), respectively
(data not shown). Five-year OS rates of the case with both
TABLE 4. Multivariate Prognostic Analysis
Variables Favorable Unfavorable Hazard Ratio 95% CI p
Age (yr) 70 70 1.348 1.030–1.764 0.030
Gender Female Male 0.735 0.534–1.010 0.058
Tumor diameter (mm) 30 30 1.597 1.165–2.190 0.004
Lymph node metastasis Absence Presence 2.293 1.693–3.104 0.001
Vascular invasion Absence Presence 1.174 0.817–1.688 0.386
Extratumoral vascular invasion
(v0–1 vs. v2)
Absence Presence 1.692 1.003–2.853 0.049
Pleural invasion Absence Presence 2.280 1.682–3.090 0.001
Lymphatic permeation Absence Presence 1.139 0.851–1.526 0.381
Histology Adeno Other 0.847 0.631–1.138 0.271
Tumor differentiation Well, moderate Poor 0.810 0.599–1.096 0.173
TABLE 5. Relationship Between the Location of Vascular
Invasion (v1 or v2) and Initially Observed Cancer Recurrence
Patterns
Cancer Recurrence Pattern
Type of
Vascular
Invasion
pv1 v2
Local recurrence 68 3 0.026
Distant recurrence 113 19
Contralateral lung 39 8 a
Brain 52 5
Bone 39 6
Liver 19 5
Adrenal 9 3
Other 5 1
a Including overlapping occurrences of recurrent patterns.
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extratumoral vascular invasion and lymphatic permeation (14
cases) were 32.7%. It is the same as in extratumoral lym-
phatic permeation (data not shown). Prognostic outcome of
extratumoral lymphatic permeation is more unfavorable than
that of extratumoral vascular invasion, but the location of
lymphatic permeation had no impact on cancer recurrence
patterns (data not shown).
Focusing on the location of vascular invasion as a
favorable prognostic factor, it was found that these data have
significant value in predicting distant metastasis and reflect
the biologic aggressiveness of proliferative tumors. This may
provide a rationale for effective systemic adjuvant treatment,
and careful follow-up management in completely resected
NSCLC can be tailored to the individual patients’ risk of the
development of recurrent NSCLC.
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